Prenaissance Plus CALCIUM CITRATE, IRON PENTACARBONYL, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, DOCUSATE SODIUM and DOCONEXENT 30; 100; 400; 250; 50; 1; 28; 25 [iU]/1; mg; [iU]/1; mg; mg; mg; mg; mg Capsule, Liquid Filled, 30-count — NDC 42192-343-30 (Billing 42192-0343-30)
This is a package of 30 capsules of Prenaissance Plus CALCIUM CITRATE, IRON PENTACARBONYL, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, DOCUSATE SODIUM and DOCONEXENT 30; 100; 400; 250; 50; 1; 28; 25 [iU]/1; mg; [iU]/1; mg; mg; mg; mg; mg Capsule, Liquid Filled from Acella Pharmaceuticals, LLC, no longer marketed, no longer in the FDA NDC Directory. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 42192-343-30 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 42192 labeler · 343 product · 30 package
- Billing quantity
- 30 EA per package
- Barcode (UPC-A, from the NDC)
- 3 4219234330 6
- FDA record last changed
- Nov 29, 2022
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 067092
- GCN: 29572
- HICL (First Databank): 036894
- AHFS class code: 20:04.04.00
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 8, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 42192-0343-30 You're viewing this Main listing | 30 CAPSULE, LIQUID FILLED in 1 CAPSULE | 2011-10-07 | — | Discontinued by firm |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Prenaissance Plus 30; 100; 400; 250; 50; 1; 28; 25 [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mgthis 42192-0343-30 | Acella | 30 capsules | — | — | Discontinued | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Acella Pharmaceuticals, LLC labeler code 42192
- NP Thyroid 60 LEVOTHYROXINE, LIOTHYRONINE 38 ug; 9 ug Tablet NDC 42192-330-01
- NP Thyroid 90 LEVOTHYROXINE, LIOTHYRONINE 57 ug; 13.5 ug Tablet NDC 42192-331-01
- PNV-Omega ascorbic acid, cholecalciferol, .alpha.-tocopherol, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium corbonate, ferrous fumarate, potassium iodide, magnesium, doconexent, icosapent 85 mg; 200 [iU]/1; 10 [iU]/1; 25 mg; 1 mg; 12 ug; 250 ug; 140 mg; 28 mg; 150 ug Capsule, Gelatin Coated NDC 42192-332-30
- Hyoscyamine Sulfate ODT .125 mg Tablet, Orally Disintegrating NDC 42192-338-01
- Hyoscyamine Sulfate SL .125 mg Tablet NDC 42192-339-01
- Hyoscyamine Sulfate TAB .125 mg Tablet NDC 42192-340-01
- Nicotinamide 750 mg; 27 mg; 850 ug; 2 mg; 50 ug; 100 ug Tablet NDC 42192-374-60
- Doxycycline 100 mg Tablet, Coated NDC 42192-501-05
- Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide 2 mg/5mL; 30 mg/5mL; 10 mg/5mL Syrup NDC 42192-607-04
- Gabapentin 250 mg/5mL Solution NDC 42192-608-05
- PHENYTOIN SODIUM 50 mg/mL Injection NDC 42192-614-03
- Naproxen 125 mg/5mL Suspension NDC 42192-619-16
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
Full prescribing information FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
About this NDC listing & data coverage
Listed without an FDA application
This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |